CDEK
← All organizations

Durata

For profitContributed to NME

Also known as: Durata Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2013

First marketed drug

May 23, 2014

First NDA

May 23, 2014

Last known activity

Apr 1, 2014

Acquired by Actavis → Allergan PLC (2015) → AbbVie on Oct 6, 2014

Timeline

2000s

  1. Jan 1, 2009

    Durata— Founded

2010s

  1. May 23, 2014

    dalbavancin— NDA Organization

  2. Oct 6, 2014

    Actavis— Acquired By

  3. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (2)

Details

Founded
Branford, CT, US Jan 1, 2009
First NDA
May 23, 2014
Last known activity
Apr 1, 2014

Designations held

  • Fast track
  • Priority review

Notes

Acquired by Actavis - 17 Nov 20114